MVRBF on OTC Markets Group
Medivir
Logo: http://www.medivir.se/v5/se/, Non-free logo, via Wikipedia4
Swedish biotechnology company
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.2 Its shares trade on OTC Markets Group under the symbol MVRBF.1 Wikipedia text CC BY-SA 4.0
Price unavailable
Last updated Oct 21, 2026.
Overview
- TickerMVRBF on OTC Markets Group1
- Industrybiotechnology industry1
- HeadquartersStockholm1
- Websitewww.medivir.com
- Legal formAktiebolag3
- LEI549300VWDGUX0WMJ1T793
- StatusActive3
- LEI statusIssued and current3
- Registered addressLunastigen 5, 141 44 Huddinge, Sweden3
- Registered withSwedish Companies Registration Office, 556238-43613
See how the biggest companies compare on our leaderboards
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.2
Timeline
- 1988Founded Founded1
Links
- Websitewww.medivir.com1
- X (Twitter)x.com/medivir1
- WikipediaMedivir
- WikidataQ10579256
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataMedivir on Wikidata
- 2WikipediaMedivir on Wikipedia
- 3
- 4Wikimedia CommonsMedivir logo by http://www.medivir.se/v5/se/, Non-free logo